dr. kunz on the impact of lanreotide’s approval for neuroendocrine tumors
Published 9 years ago • 796 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
1:33
dr. kunz on potential of immunotherapy in neuroendocrine tumors
-
1:13
dr. kunz on sequencing agents for the treatment of pancreatic nets
-
2:05
dr. kunz on treatment options for pancreatic nets
-
1:41
dr. kunz on the clarinet study for gep-nets
-
4:39
introduction and overview of the diagnosis and characterization of neuroendocrine tumors
-
6:01
targeted therapies in pancreatic neuroendocrine tumors
-
3:06
treating neuroendocrine tumors with chemotherapy
-
5:28
future advances in pancreatic neuroendocrine tumors
-
1:24
dr. kunz on classifying and predicting response in nets
-
17:52
introduction to neuroendocrine tumors. pamela kunz, md, stanford
-
1:28
dr. phan on the importance of the approval of lanreotide and its known side effects
-
9:13
combination and sequential treatment in pnets
-
21:49
the latest in systemic treatments & considerations for treatment sequencing • dr. kunz • lacnets
-
12:32
diagnosing pancreatic neuroendocrine tumors
-
1:47
dr. kunz on the identification of molecular subtypes of gastric cancer
-
20:35
net primer; pamela kunz, md, stanford university
-
3:10
can immunotherapy be used for neuroendocrine tumors?
-
1:14
dr. phan on clarinet subgroup analysis
-
2:11
dr. pavel on the pfs with lanreotide autogel in the clarinet forte trial